[Comment] The rise of thyroid cancer incidence in adolescents and young adults

In The Lancet Diabetes & Endocrinology, Mengmeng Li and colleagues analysed global trends in thyroid cancer incidence from 2003 to 2017 and contemporary burden for the year 2022 among adolescents and young adults (AYAs; aged 15 to 39 years),1 extending previous studies in older adult populations. Using validated methods and data from the Cancer Incidence in Five Continents Plus and from the Global Cancer Observatory databases, the authors observed increasing incidence trends in nearly all of the 185 included countries, with average annual percent changes exceeding 10% in six.